CALL/TEVA PHARMACEUTICAL INDUSTRIES/20/1/20.09.24

CALL/TEVA PHARMACEUTICAL INDUSTRIES/20/1/20.09.24 Stock

DE000GG26LF0

Real-time BOERSE MUENCHEN 08:27:01 2024-05-23 EDT
0.482 ^EUR	+4.33%

Current month	+171.76%
1 month	+524.32%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Chart CALL/TEVA PHARMACEUTICAL INDUSTRIES/20/1/20.09.24

Latest news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Teva and Alvotech Announce SIMLANDI Injection Now Available in the U.S.	05-22	AQ
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	05-20	BU
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	05-20	AQ
Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing	05-17	MT

More news

Quotes 5-day view

Date	Price	Change
24-05-23	0.482	+4.33%
24-05-22	0.462	+18.16%
24-05-21	0.391	-3.93%
24-05-20	0.407	+20.77%
24-05-17	0.337	-7.67%

Real-time BOERSE MUENCHEN

Last update May 23, 2024 at 08:27 am

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer	Goldman Sachs
WKN	GG26LF
ISIN	DE000GG26LF0
Date issued	2024-01-24
Strike	20 $
Maturity	2024-09-20 (120 Days)
Parity	1 : 1
Emission price	0.09 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.55 €
Lowest since issue	0.059 €
Spread	0.07 €
Spread %	13.46%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Sector

More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

16.88 USD

Average target price

17.54 USD

Spread / Average Target

+3.89%

Consensus